Target intelligence / Profile preview

Mitogen-activated protein kinase kinase 7 (MKK7)

Target
MKK7
Molecular classification
Enzyme, Protein kinase (specifically, a dual-specificity MAP2K family member), Signal transduction molecule
01

Overview

Mitogen‑activated protein kinase kinase 7 (MKK7, also known as MAP2K7) is a dual-specificity protein kinase that functions as an essential activator of the c-Jun N-terminal kinases (JNKs) within the mitogen‑activated protein (MAP) kinase signaling cascade. It phosphorylates and activates JNK but not p38 or ERKs. MKK7 plays a central role in transmitting extracellular signals—such as cytokines or environmental stresses—to intracellular effectors that regulate gene expression, apoptosis, inflammation, and cellular differentiation. It is widely expressed across tissues and acts upstream of key cellular decisions involving proliferation versus programmed cell death. Dysregulation of this pathway has been implicated in cancer development/progression and inflammatory diseases[2][7].

Other names
MKK7MAP2K7Dual specificity mitogen-activated protein kinase kinase 7JNKK2 (c-Jun N-terminal kinases Kinase 2)PRKMK7
02

Mechanism of action

Drugs or tool compounds that inhibit MKK7 would block phosphorylation and activation of downstream c-Jun N-terminal kinases (JNKs), thereby modulating cellular responses to stress, inflammation, or apoptosis signals

03

Biological functions

Signal transduction (activates the JNK pathway)Cell stress responseApoptosis regulationInflammatory response
04

Disease associations

Cancer (implicated in tumorigenesis and cancer cell survival via JNK signaling)Inflammation
05

Safety considerations

Disruption of normal cell stress responses and apoptosis if inhibited systemically.Possible effects on immune function due to its role in inflammatory signaling.Off-target effects due to similarity with other MAPK pathway components.
06

Biomarkers

No widely used clinical biomarkers specific to MKK7 at this time.Phosphorylation status of downstream targets such as JNK may be used experimentally.

Beyond the preview

Go deeper on Mitogen-activated protein kinase kinase 7 (MKK7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitogen-activated protein kinase kinase 7 (MKK7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call